Research Article

eVITAL: A Preliminary Taxonomy and Electronic Toolkit of Health-Related Habits and Lifestyle

Table 4

Evaluation of items included in the eVITAL toolkit(1).

1. Domain: health descriptors

Evaluation Instruments
History—Level 0 Sociodemographic inventory
History—Level 1 Family medical history
Personal medical history
Medication, hormone use, and alternative treatments
Immunization history
History—Level 2
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 2

2. Domain: cognition

Evaluation Instruments
History—Level 0 Screening for cognitive problems
History—Level 1 Cognitive reserve (CR)
History—Level 2 (i) Cognitive risk factors
(ii) Cognitive reserve adjusted for cognitive risk (CRar)
(iii) Stage of change, objective [17]
History—Level 3 Global cognitive reserve (gCR)
Examination—Level 0
Examination—Level 1
Examination—Level 2 7-minute test [19, 20]
Examination—Level 3 (i) Luria’s test [21]
(ii) Benton’s visual recognition test [22]
(iii) Trail making test-A (TMT-A) [23]
(iv) Finger electronic tapping test (FETT) [24]

3. Domain: vitalty and stress

Evaluation Instruments
History—Level 0 Screening for emotional state
History—Level 1 (i) Optimism-LOT-R: life orientation test-revised [25]
(ii) Emotional stress—Questions 5–9, SF-36: social functioning-36 question scale [26, 27]/MHI-5.
(iii) Social isolation—STAKES [28]
(iv) Social support—Oslo [29]
(v) Anxiety/depression—HAD: hospital anxiety and depression scale [30]
History—Level 2 (i) NEO Pi-R: revised NEO personality inventory [31]
(ii) Psychological well-being [32, 33]
(iii) Sexuality quality of life: sexuality subscales [34, 35]
(iv) Stress—HAD [30, 36]
(v) Stage of change, objective [17]
History—Level 3 (i) Social readjustment rating scale [37]
(ii) Type A personality—ERCTA: escala retiro de patrón de conducta tipo A (scale of Type A behavior pattern) [38]
(iii) Aggression subscale—ZKPQ: Zuckerman-Kuhlman’s personality questionnaire [39]
(iv) Obsessions—SPPI: standardized polyvalent psychiatric interview [40]
(v) Hypochondriasis—SPPI [40]
(vi) Gender-specific medical evaluation, including breast cancer risk assessment [41]
Examination—Level 0
Examination—Level 1
Examination—Level 2 Basic allostatic load: blood pressure, waist-to-hip ratio, total/HDL cholesterol, HDL, glycated hemoglobin, CRP
Examination—Level 3 Expanded allostatic load: add DHEA-S and urinary cortisol

4. Domain: sleep

Evaluation Instruments
History—Level 0 Screening for insomnia and hypersomnia
History—Level 1 (i) Insomnia—SPPI [40]
(ii) Somnolence—Epworth sleepiness scale [4244]
(iii) Specific sleep-related symptoms
(iv) Sleep habits
History—Level 2 Stage of change, objective [17]
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 3 Polysomnography

5. Domain: diet and exercise

Evaluation Instruments
Instruments DIETInstruments EXERCISE
History—Level 0Screening for change in appetite (SSPI)Activity level
History—Level 1Eating habitsExercise habits
Table of mealtimesExercise readiness—Par-Q: physical activity readiness questionnaire [45]
Appetite-SPPI [40]Fatigue-adapted SPPI [40]
Subclassification BMIEstimated METs
Metabolic classification (combines weight status and activity level) (16 levels)
Classification as recommendations: 5 levels
Readiness to change—diet and exercise—subjectiveReadiness to change—diet and exercise—objective
History—Level 2CFCA-food frequency questionnaire [46]
Digestive symptoms, food intolerance, dental problemsMusculoskeletal physical barriers to exercise
Readiness to change—diet and exercise—objectiveReadiness to change—diet and exercise—objective
History—Level 3
Examination—Level 0 (i) Waist circumference
(ii) Reported body mass index (BMI) from reported weight and height
Examination—Level 1 (i) Body composition—subclassification BMI
(ii) Waist-to-hip ratio
(iii) BMI adjusted for waist circumference [47], (BMIa)
Examination—Level 2 (i) Basic lab work: total/HDL cholesterol, HDL, glycated hemoglobin, C-reactive protein, microalbumin, glucose, insulin
(ii) Blood pressure, heart rate.
(iii) Adjusted BMI (for adult weight gain, triglyceride/HDL, blood pressure, fasting glucose, and presence or absence of sleep apnea and osteoarthritis (BMIar))
(iv) Body composition (triceps skin fold), estimated muscle mass (arm circumference)
(v) Insulin resistance-HOMA-IR [48]
Examination—Level 33-day food record analyzed by nutritionistIndirect METs calculated through compendium of physical activities—CPHA [49]
Hand strength via dynamometry
(i) Body composition via BIA or DEXA(i) Somatometry
(ii) Nutritional calculator(ii) Ergometry
(iii) Direct METs measurement

6. Domain: substance abuse

Evaluation Instruments
History—Level 0 Screening for substance abuse
History—Level 1 Inventory: use and abuse of prescription medications, use of caffeine, nicotine, alcohol, and illicit drugs
Adapted CAGE questionnaire for each substance [50, 51]
Stage of change for each substance, subjective
History—Level 2 (i) Stage of change for each substance, objective
(ii) For smokers: Fagerström’s test of nicotine dependence [52, 53]
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 3 Nicotine—CO-oximetry
Alcohol—GGT, MCV
Drug levels in urine/blood/hair tests

7. Domain: other risk habits

Evaluation Instruments
History—Level 0
History—Level 1 (i) Medication adherence.
(ii) Inventory of risk behaviors: risky sexual behavior, dangerous sports, gambling, dangerous driving, potentially dangerous travel, internet/technology addiction.
(iii) Readiness to change—subjective
History—Level 2 Readiness to change—objective
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 3

(1)All tests are fully described at the eVITAL webpage (http://www.longevidad.org/). References can be downloaded at http://www.longevidad.org/descargas/011anexo_bibliografia_final.pdf.
BIA: bioelectrical impedance analysis; CO: carbon monoxide; CRP: C-reactive protein; DEXA: dual-energy X-ray absorptiometry; GGT: gamma-glutamyl transpeptidase; HDL: high-density lipoprotein; HOMA: homeostatic model assessment; MCV: mean corpuscular volume; MHI: mental health index.